Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

FM04

FM04
FM04 is an orally active and highly potent inhibitor of P-glycoprotein (P-gp) with an EC50 value of 83 nM. FM04 can interact with Q1193 and I1115 in human P-gp nucleotide binding domain 2 (NBD2). Thereby disrupting the R262-Q1081-Q1118 interaction pocket and uncoupling the ICL2-NBD2 interaction, thereby inhibiting P-gp. FM04 can be used in the treatment of cancer and tumors.
Catalog No. T72055Cas No. 1807320-40-6
Select Batch
Purity:99.84%
Contact us for more batch information
Resource Download

FM04

Catalog No. T72055Cas No. 1807320-40-6
FM04 is an orally active and highly potent inhibitor of P-glycoprotein (P-gp) with an EC50 value of 83 nM. FM04 can interact with Q1193 and I1115 in human P-gp nucleotide binding domain 2 (NBD2). Thereby disrupting the R262-Q1081-Q1118 interaction pocket and uncoupling the ICL2-NBD2 interaction, thereby inhibiting P-gp. FM04 can be used in the treatment of cancer and tumors.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Pack SizePriceAvailabilityQuantity
1 mg$195In Stock
5 mg$483In Stock
10 mg$692In Stock
25 mg$1,080In Stock
50 mg$1,490In Stock
100 mg$1,970In Stock
500 mg$3,930In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "FM04"

Product Introduction

Bioactivity
Description
FM04 is an orally active and highly potent inhibitor of P-glycoprotein (P-gp) with an EC50 value of 83 nM. FM04 can interact with Q1193 and I1115 in human P-gp nucleotide binding domain 2 (NBD2). Thereby disrupting the R262-Q1081-Q1118 interaction pocket and uncoupling the ICL2-NBD2 interaction, thereby inhibiting P-gp. FM04 can be used in the treatment of cancer and tumors.
Targets&IC50
P-gp:83 nM(EC50)
In vitro
FM04 (100 μM) exhibits competition with its photoaffinity derivative XC4 in LCC6MDR cells.[1]
FM04 inhibits P-glycoprotein with an EC50=83 nM, where the EC50 value refers to the effective modulator concentration IC50 (=3.8 nM) that reduces paclitaxel (PTX) by half in the P-gp overexpressing cell line LCC6MDR.[1]
Chemical Properties
Molecular Weight415.48
FormulaC26H25NO4
Cas No.1807320-40-6
Storage & Solubility Information
StorageShipping with blue ice.
Solubility Information
DMSO: 55 mg/mL (132.38 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.4069 mL12.0343 mL24.0685 mL120.3427 mL
5 mM0.4814 mL2.4069 mL4.8137 mL24.0685 mL
10 mM0.2407 mL1.2034 mL2.4069 mL12.0343 mL
20 mM0.1203 mL0.6017 mL1.2034 mL6.0171 mL
50 mM0.0481 mL0.2407 mL0.4814 mL2.4069 mL
100 mM0.0241 mL0.1203 mL0.2407 mL1.2034 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy FM04 | purchase FM04 | FM04 cost | order FM04 | FM04 chemical structure | FM04 in vitro | FM04 formula | FM04 molecular weight